EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties

Anna Duda-Madej iD, Patrycja Lipska iD, Szymon Viscardi iD, Hanna Bazan iD, Jakub Sobieraj iD

Cells · 08.07.2025 · 14 (14) · 1041

DOI: 10.3390/cells14141041 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 08.07.2025. Verfasst von Anna Duda-Madej und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chałubińskiego 4, 50-368 Wrocław, Poland. Hauptthemen laut MEDLINE: Berberine, Skin Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty of Medicine, Wroclaw Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skin cancers are associated with a significant psychological burden across all age groups, particularly as their global incidence continues to rise. Ultraviolet (UV) radiation—primarily UVA and UVB—remains the leading etiological factor, inducing DNA mutations in key genes such as TP53 and BRAF. Among skin cancers, basal cell carcinoma (BCC) is the most prevalent and typically indolent. In contrast, squamous cell carcinoma (SCC) tends to be more invasive, while melanoma is the most aggressive and prone to metastasis. Melanoma is especially concerning due to its rapid dissemination and its occurrence not only on the skin but also in ocular, mucosal, and nail tissues. These challenges, along with rising treatment resistance and mortality, underscore the urgent need for novel anticancer agents. Berberine—a plant-derived isoquinoline alkaloid—has attracted increasing attention for its broad-spectrum anticancer potential, including against skin cancers. In this review, we summarize current evidence regarding berberine’s mechanisms of action in melanoma and SCC, emphasizing both its preventive and therapeutic effects. We further explore its potential as an adjuvant agent in combination with conventional treatments, offering a promising avenue for enhancing the clinical outcomes of skin cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineSkin NeoplasmsAntineoplastic AgentsHumansMelanomaAnimalsBasal Cell Carcinoma

Stichwörter der Autor:innen

adjuvant therapyanticancer activityberberinemelanomanatural compoundsskin neoplasmssquamous cell carcinoma

Substanzen

BerberineAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Medicine, Wroclaw Medical University, Chałubińskiego 4, 50-368 Wrocław, Poland.
  • Faculty of Medicine, Wroclaw Medical University, Ludwika Pasteura 1, 50-367 Wrocław, Poland.

ORCID-Profile: Anna Duda-Madej, Patrycja Lipska, Szymon Viscardi, Hanna Bazan, Jakub Sobieraj

Förderung

  • Faculty of Medicine, Wroclaw Medical University

Zitieren

APA

Duda-Madej, A., Lipska, P., Viscardi, S., Bazan, H., & Sobieraj, J. (2025). Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties. Cells, 14(14), 1041. https://doi.org/10.3390/cells14141041

Vancouver

Duda-Madej A, Lipska P, Viscardi S, Bazan H, Sobieraj J. Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties. Cells. 2025;14(14):1041. doi:10.3390/cells14141041

BibTeX
@article{DudaMadej2025,
  author = {Duda-Madej, Anna and Lipska, Patrycja and Viscardi, Szymon and Bazan, Hanna and Sobieraj, Jakub},
  title = {Targeting Skin Neoplasms: A Review of Berberine’s Anticancer Properties},
  journal = {Cells},
  year = {2025},
  volume = {14},
  number = {14},
  pages = {1041},
  doi = {10.3390/cells14141041}
}
Kostenlos starten →